With multi-state agreement worth $86M, Indivior moves to resolve more opioid litigation

Suboxone maker Indivior has spent years dealing with allegations related to its role in the United States opioid epidemic, inking several settlements over that span and even witnessing its former CEO land a six-month prison term.